Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release

Journal of Controlled Release

Volumn 138, Issue 2, 2009, Pages 177-184

  Papadimitriou, Sofia ^a   Bikiaris, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Caprolactone poly(propylene succinate); Nanoparticles; Release behavior; Tibolone

Indexed keywords

ALIPHATIC COPOLYESTERS; CAPROLACTONE; CONTROLLED DRUG RELEASE; COPOLYESTERS; COPOLYMER COMPOSITIONS; CORE-SHELL NANOPARTICLES; DRUG LOADING; DRUG RELEASE; DRUG RELEASE STUDY; ENCAPSULATION EFFICIENCY; IN-CORE; IN-VITRO; MODEL DRUGS; MONOMER RATIO; NANOPARTICLE SIZES; POLY(PROPYLENE SUCCINATE); RELEASE BEHAVIOR; RELEASE RATE; SELF-ASSEMBLED; SEM; SOLVENT EVAPORATION METHOD; SPHERICAL SHAPE; TEM; TIBOLONE;

BIOCOMPATIBILITY; COPOLYMERIZATION; COPOLYMERS; CRYSTALLINE MATERIALS; ENCAPSULATION; NANOPARTICLES; RING OPENING POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

PROPYLENE;

COPOLYMER; NANOPARTICLE; PROPYLENE SUCCINATE CAPROLACTONE COPOLYMER; TIBOLONE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOENCAPSULATION; NANOENGINEERING; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

BIOCOMPATIBLE MATERIALS; CELL LINE; CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NORPREGNENES; PARTICLE SIZE; POLYESTERS; SOLUBILITY; SURFACE PROPERTIES;

EID: 67651230397     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.05.013     Document Type: Article

References (45)

1. Barratt G. Review. Colloidal drug carriers: achievements and perspectives. CMLS, Cell. Mol. Life Sci. 60 1 (2003) 21-37
2. Couvreur P., and Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm. Res. 23 7 (2006) 1417-1450
3. Rawat M., Singh D., Saraf S., and Saraf S. Nanocarriers: promising vehicle for bioactive drugs. Biol. Pharm. Bull. 29 9 (2006) 1790-1798
4. Stolnik S., Illum L., and Davis S.S. Long circulating microparticulate drug carriers. Adv. Drug Deliv. Rev. 16 2-3 (1995) 195-214
5. Kataoka K., Harada A., and Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 47 1 (2001) 113-131
6. Torchilin V.P. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv. Drug Deliv. Rev. 54 2 (2002) 235-252
7. Torchilin V.P., and Trubetskoy V.S. Which polymers can make nanoparticulate drug carriers long-circulating?. Adv. Drug Deliv. Rev. 16 2-3 (1995) 141-155
8. Orive G., Gascon A.R., Hernandez R.M., Gil A.D., and Perdaz J.L. Techniques: new approaches to the delivery of biopharmaceuticals. Trends Pharmacol. Sci. 25 7 (2004) 382-387
9. Owens III D.E., and Peppas N.A. Review. Opsonization, biodistribution and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307 1 (2006) 93-102
10. Gryparis C., Mattheolabakis G., Bikiaris D., and Avgoustakis K. Effect of conditions of preparation on the size and encapsulation properties of PLGA-mPEG nanoparticles of cisplatin E. Drug Deliv. 14 6 (2007) 371-380
11. Pierri E., and Avgoustakis K. Poly(lactide)-poly(ethylene glycol) micelles as a carrier for griseofulvin. J. Biomed. Mater. Res. - Part A 75 3 (2005) 639-647
12. Zhang, Hu Y., Jiang X., Yang C., Lu W., and Yang Y.H. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J. Control. Release 96 1 (2004) 135-148
13. Jeong Y.I., Kang M.-K., Sun H.-S., Kang S.-S., Kim H.-W., Moon K.-S., Lee K.-J., Kim S.-H., and Jung S. All-trans-retinoic acid release from core-shell type nanoparticles of poly(ε-caprolactone)/poly (ethylene glycol) diblock copolymer. Int. J. Pharm. 273 1-2 (2004) 95-107
14. Layre A., Couvreur P., Chacun H., Richard J., Passirani C., Requier D., Benoit J.P., and Gref R. Novel composite core-shell nanoparticles as busulfan carriers. J. Control. Release 111 3 (2006) 271-280
15. Zhang Y., and Zhuo R.-X. Synthesis and in vitro drug release behaviour of amphiphilic triblock copolymer nanoparticles based on poly(ethylene glycol) and polycaprolactone. Biomaterials 26 33 (2005) 6736-6742
16. Zhang Y., Wang C., Yang W., Shi B., and Fu S. Tri-component diblock copolymers of poly(ethylene glycol)-poly(ε-caprolactone-co-lactide): synthesis, characterization and loading captothecin. Colloid Polym. Sci. 283 11 (2005) 1246-1252
17. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., and Rudzinski W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70 1-2 (2001) 1-20
18. Sinha V.R., Bansal K., Kaushic R., Kumria R., and Trehan A. Poly-ε-caprolactone microspheres and nanospheres an overview. Int. J. Pharm. 278 1 (2004) 1-23
19. Barbato F., La Rotonda M.I., Maglio G., Palumbo R., and Quaglia F. Biodegradable microspheres of novel segmented poly(ether-ester-amide)s based on poly(ε-caprolactone) for the delivery of bioactive compounds. Biomaterials 22 11 (2001) 1371-1378
20. Papadimitriou S.A., Papageorgiou G.Z., and Bikiaris D.N. Crystallization and enzymatic degradation of novel poly(ε-caprolactone-co-propylene succinate) copolymers. Eur. Polym. J. 44 7 (2008) 2356-2366
21. Bikiaris D.N., Papageorgiou G.Z., Papadimitriou S.A., Karavas E., and Avgoustakis K. Novel biodegradable polyester poly(propylene succinate): synthesis and application in the preparation of solid dispersions and nanoparticles of fluvastatin. AAPS Pharm. Sci. Tech. 10 1 (2009) 138-146
22. Papanikolaou S., Ruiz-Sanchez P., Pariset B., Blanchard F., and Fick M. High production of 1,3-propanediol from industrial glycerol by a newly isolated Clostridium butyricum strain. J. Biotechnol. 77 2-3 (2000) 191-208
23. Bikiaris D.N., Papageorgiou G.Z., and Achilias D.S. Synthesis and comparative biodegradability studies of three poly(alkylene succinate)s. Polym. Degrad. Stab. 91 1 (2006) 31-43
24. Sator K., Sator M.O., Sator P.G., Egarter C., and Huber J.C. Effects of tibolone on selectins in postmenopausal women. Maturitas 53 2 (2006) 166-170
25. Kloosterboer H.J. Tissue-selectivity: the mechanism of action of tibolone. Maturitas 48 1 (2004) S30-S40
26. Reeda M.J., and Kloosterboer H.J. Tibolone: a selective tissue estrogenic activity regulator (STEAR). Maturitas 48 1 (2004) S4-S6
27. Papadimitriou S.A., Bikiaris D., and Avgoustakis K. Microwave-induced enhancement of the dissolution rate of poorly water-soluble tibolone from polyethylene glycol solid dispersions. J. Appl. Polym. Sci. 108 2 (2008) 1249-1258
28. Roupakias C.P., Bikiaris D.N., and Karayannidis G.P. Synthesis, thermal characterization, and tensile properties of alipharomatic polyesters derived from 1,3-propanediol and terephthalic, isophthalic, and 2,6-naphthalenedicarboxylic acid. J. Polym. Sci., A, Polym. Chem. 43 17 (2005) 3998-4011
29. Seretoudi G., Bikiaris D., and Panayiotou C. Synthesis, characterization and biodegradability of poly(ethylene succinate)/poly(1-caprolactone) block copolymers. Polymer 43 20 (2002) 5405-5415
30. Avgoustakis K., Beletsi A., Panagi Z., Klepetsanis P., Karydas A.G., and Ithakissios D.S. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Release 79 1-3 (2002) 123-135
31. De Haan, Pieter, Immediate-release pharmaceutical dosage form comprising polymorphous Tibolone. EP 1 499 278 B1, 2004.
32. Papadimitriou S., Bikiaris D.N., Chrissafis K., Paraskeuopoulos K.M., and Mourtas S. Synthesis, characterization, and thermal degradation mechanism of fast biodegradable PPSu/PCL copolymers. J. Polym. Sci., A, Polym. Chem. 45 22 (2007) 5076-5090
33. Barham P.J., Keller A., Otum E.L., and Holmes P.A. Crystallization and morphology of a bacterial thermoplastic: poly-3-hydroxybutyrate. J. Mater. Sci. 19 9 (1984) 2781-2794
34. Papageorgiou G.Z., and Bikiaris D.N. Crystallization and melting behavior of three biodegradable poly(alkylene succinates). A comparative study. Polymer 46 26 (2005) 12081-12092
35. Athanasiou K.A., Niederauer G.G., and Agrawal C.M. Sterilization, toxicity, biocompatibility, and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 17 2 (1996) 93-102
36. Ge H., Hu Y., Jiang X., Cheng D., Yuan Y., Bi H., and Yang C. Preparation, characterization and drug release behaviors of drug nimodipine-loaded poly(ε-caprolactone)-poly(ethylene oxide)-poly(ε-caprolactone) amphiphilic triblock copolymer micelles. J. Pharm. Sci. 91 6 (2002) 1463-1473
37. Bikiaris D.N., Papageorgiou G.Z., Achilias D.S., Pavlidou E., and Stergiou A. Miscibility and enzymatic degradation studies of poly(ε-caprolactone)/poly(propylene succinate) blends. Eur. Polym. J. 43 6 (2007) 2491-2503
38. Gaumet M., Vargas A., Gurny R., and Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm. 69 1 (2008) 1-9
39. Bikiaris D., Papageorgiou G.Z., Stergiou A., Pavlidou E., Karavas E., Kanaze F., and Georgarakis M. Physicochemical studies on solid dispersions of poorly-water soluble drugs. Evaluation of capabilities and limitations of thermal analysis techniques. Thermochim. Acta 439 1-2 (2005) 58-67
40. Genard Sas A.J.M.T., and van Doornum E.M. Pharmaceutical Composition which Contains a Pharmaceutically Suitable Carrier and the Compound Having the Structure (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one, US Patent 5,037,817 (1991)
41. Ge H., Hu Y., Yang S., Jiang X., and Yang C. Preparation, characterization and drug release behaviors of drug-loaded ε-caprolactone/l-lactide copolymer nanoparticles. J. Appl. Polym. Sci. 75 7 (2000) 874-882
42. Gref R., Minamitake Y., Peracchia M.T., Trebetskoy V.S., Torchilin V.P., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 5153 (1994) 1600-1603
43. Hu Y., Jiang X., Ding Y., Zhang L., Yang C., Zhang J., Chen J., and Yang Y. Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles. Biomaterials 24 13 (2003) 2395-2404
44. Chawla J.S., and Amiji M.M. Biodegradable poly(ε-caprolactone) nanoparticles for tumor targeted delivery of tamoxifene. Int. J. Pharm. 249 (2002) 127-137
45. Soo P.L., Luo L., Mayasinger D., and Eisenberg A. Incorporation and release of hydrophobic probes in biocompatible polycaprolactone-block-poly(ethylene oxide) micelles: implications of drug delivery. Langmuir 18 25 (2002) 9996-10004